These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34115827)

  • 61. The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis.
    Stutz N; Johnson RD; Wood GS
    J Am Acad Dermatol; 2012 Dec; 67(6):1327.e1-10. PubMed ID: 22884443
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.
    Liu F; Gao Y; Xu B; Xiong S; Yi S; Sun J; Chen Z; Liu X; Li Y; Lin Y; Wen Y; Qin Y; Yang S; Li H; Tejasvi T; Tsoi L; Tu P; Ren X; Wang Y
    Blood; 2022 Jan; 139(4):554-571. PubMed ID: 34582557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
    McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
    J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.
    Mao X; Orchard G; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    J Invest Dermatol; 2006 Jun; 126(6):1388-95. PubMed ID: 16614728
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Two cases of mycosis fungoides with large cell transformation with KMT2A rearrangements.
    Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
    J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
    Tensen CP
    J Invest Dermatol; 2015 Sep; 135(9):2153-2154. PubMed ID: 26269406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
    Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
    J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A multidisciplinary approach to the diagnosis of cutaneous T-cell lymphomas.
    Payne CM; Grogan TM; Spier CM; Bjore CG; Richter LC; Cromey DW; Rangel CS
    Ultrastruct Pathol; 1992; 16(1-2):99-125. PubMed ID: 1557836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome.
    Błażewicz I; Olszewska B; Stawczyk-Macieja M; Jaśkiewicz M; Nowicki RJ; Sokołowska-Wojdyło M
    Postepy Dermatol Alergol; 2021 Apr; 38(2):289-294. PubMed ID: 34408597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma.
    Muche JM; Lukowsky A; Asadullah K; Gellrich S; Sterry W
    Blood; 1997 Aug; 90(4):1636-42. PubMed ID: 9269783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
    Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.
    Moreno-Vílchez C; Servitje O; Íñiguez-Arroyo Ó; Muniesa C
    Actas Dermosifiliogr; 2024 Sep; 115(8):T766-T772. PubMed ID: 38972577
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of the novel Sezary lymphoma cell line BKP1.
    Boudjarane J; Essaydi A; Farnault L; Popovici C; Lafage-Pochitaloff M; Beaufils N; Berda-Haddad Y; Lacroix R; Nicolino-Brunet C; Le Treut T; Zattara H; Gabert J; Kahn-Perlès B; Costello R
    Exp Dermatol; 2015 Jan; 24(1):60-2. PubMed ID: 25314094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cutaneous T-Cell Lymphoma: Current and Emerging Therapies.
    Dai J; Duvic M
    Oncology (Williston Park); 2023 Feb; 37(2):55-62. PubMed ID: 36862846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
    Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
    Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.